FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085002947> ?p ?o ?g. }

• W2085002947 endingPage "510" @default.
• W2085002947 startingPage "501" @default.
• W2085002947 abstract "The biology of the low-density lipoprotein (LDL) receptor has been examined in detail, and a paradigm for LDL metabolism has evolved from comparative studies of cholesterol metabolism in a variety of cells cultured from normal individuals and subjects with familial hypercholesterolemia (FH). Cultured cells from patients with homozygous FH lack a functional LDL receptor and show diminished LDL clearance, induction of the enzyme hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase, increased cholesterol synthesis, decreased cholesterol ester production, and depleted cholesterol ester stores. The observed decrease in the fractional catabolic rate (FCR) of LDL is attributed to the mutated LDL receptor gene. However, in the experimental animal model of this disease, the Watanabe heritable hyperlipidemic (WHHL) rabbit, cholesterol ester stores are increased, while hepatic cholesterol synthesis is decreased. Furthermore, in humans HMG-CoA reductase is suppressed, and the LDL apolipoprotein (apo) B production rate is increased in patients with FH. These findings raise questions about the adequacy of the paradigm in understanding hepatic cholesterol metabolism in vivo. In humans, apoB metabolism is believed to be principally determined by the liver, where apoB is both synthesized and catabolized. Assuming the neutral lipid content of the liver is the major determinant of apoB metabolism, we postulated that the changes in apoB metabolism in FH are predictable when based on the assumption of an increase in hepatic cholesterol and cholesterol ester content, as observed both in the WHHL rabbit and in humans. We examined this hypothesis in vivo in patients with heterozygous FH by using tracer kinetic methodology and have used similar data from normal and hypertriglyceridemic (HTG) subjects as controls. Whereas normal and HTG subjects secrete apoB primarily as large, triglyceride-enriched very-low-density lipoprotein (VLDL), heterozygous FH patients have an absolute decrease in apoB production and secrete almost 40% of apoB as smaller intermediate-density lipoprotein (IDL)/LDL. In normal humans, about half of secreted apoB is catabolized rather than being converted to LDL. In HTG subjects two thirds of apoB follows this same route, by which VLDL remnants remaining after triglyceride hydrolysis are largely returned to the liver. In contrast, in FH subjects secreted apoB is fully converted to LDL. Thus, although total apoB secretion is reduced in FH subjects, total LDL production is greater than in either normal or HTG subjects. Under basal conditions the elevated LDL in heterozygous FH is due to both decreased LDL receptor-mediated catabolism and increased LDL production. However, the number of LDL receptors actually expressed is suppressed below the number of potentially functional receptors.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2085002947 created "2016-06-24" @default.
• W2085002947 creator A5015552330 @default.
• W2085002947 creator A5071684579 @default.
• W2085002947 creator A5080489320 @default.
• W2085002947 date "1994-04-01" @default.
• W2085002947 modified "2023-10-17" @default.
• W2085002947 title "ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm." @default.
• W2085002947 cites W147862716 @default.
• W2085002947 cites W1550638578 @default.
• W2085002947 cites W1762207328 @default.
• W2085002947 cites W1813690525 @default.
• W2085002947 cites W1883383114 @default.
• W2085002947 cites W1892978379 @default.
• W2085002947 cites W1906747518 @default.
• W2085002947 cites W1935226170 @default.
• W2085002947 cites W1940855330 @default.
• W2085002947 cites W1940867966 @default.
• W2085002947 cites W1968228738 @default.
• W2085002947 cites W1969876638 @default.
• W2085002947 cites W1974740182 @default.
• W2085002947 cites W1977359700 @default.
• W2085002947 cites W1981201033 @default.
• W2085002947 cites W1983853341 @default.
• W2085002947 cites W1989958072 @default.
• W2085002947 cites W1991245488 @default.
• W2085002947 cites W1991997766 @default.
• W2085002947 cites W1996345715 @default.
• W2085002947 cites W2001539608 @default.
• W2085002947 cites W2002700276 @default.
• W2085002947 cites W2004410658 @default.
• W2085002947 cites W2005915459 @default.
• W2085002947 cites W2006446831 @default.
• W2085002947 cites W2011054347 @default.
• W2085002947 cites W2011084569 @default.
• W2085002947 cites W2011369274 @default.
• W2085002947 cites W2016678257 @default.
• W2085002947 cites W2019341675 @default.
• W2085002947 cites W2020719752 @default.
• W2085002947 cites W2027763516 @default.
• W2085002947 cites W2030028094 @default.
• W2085002947 cites W2031751032 @default.
• W2085002947 cites W2036879096 @default.
• W2085002947 cites W2036989162 @default.
• W2085002947 cites W2042536822 @default.
• W2085002947 cites W2043581240 @default.
• W2085002947 cites W2045315999 @default.
• W2085002947 cites W2048895138 @default.
• W2085002947 cites W2051742401 @default.
• W2085002947 cites W2051812340 @default.
• W2085002947 cites W2053916731 @default.
• W2085002947 cites W2058060182 @default.
• W2085002947 cites W2059662117 @default.
• W2085002947 cites W2061914486 @default.
• W2085002947 cites W2063326615 @default.
• W2085002947 cites W2063787041 @default.
• W2085002947 cites W2066872473 @default.
• W2085002947 cites W2067635119 @default.
• W2085002947 cites W2084744450 @default.
• W2085002947 cites W2088681386 @default.
• W2085002947 cites W2095145439 @default.
• W2085002947 cites W2095272104 @default.
• W2085002947 cites W2101816307 @default.
• W2085002947 cites W2102953109 @default.
• W2085002947 cites W2103402907 @default.
• W2085002947 cites W2103411035 @default.
• W2085002947 cites W2104602624 @default.
• W2085002947 cites W2104720567 @default.
• W2085002947 cites W2105732728 @default.
• W2085002947 cites W2110091523 @default.
• W2085002947 cites W2113497883 @default.
• W2085002947 cites W2114689977 @default.
• W2085002947 cites W2120225855 @default.
• W2085002947 cites W2130576404 @default.
• W2085002947 cites W2133333129 @default.
• W2085002947 cites W2133674817 @default.
• W2085002947 cites W2134622570 @default.
• W2085002947 cites W2136057441 @default.
• W2085002947 cites W2150468907 @default.
• W2085002947 cites W2165550596 @default.
• W2085002947 cites W2168017436 @default.
• W2085002947 cites W2181825562 @default.
• W2085002947 cites W2188634004 @default.
• W2085002947 cites W2189125862 @default.
• W2085002947 cites W2341319159 @default.
• W2085002947 cites W2344422294 @default.
• W2085002947 cites W2407480007 @default.
• W2085002947 cites W2409664431 @default.
• W2085002947 cites W2409872030 @default.
• W2085002947 cites W34393042 @default.
• W2085002947 doi "https://doi.org/10.1161/01.atv.14.4.501" @default.
• W2085002947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8148348" @default.
• W2085002947 hasPublicationYear "1994" @default.
• W2085002947 type Work @default.
• W2085002947 sameAs 2085002947 @default.
• W2085002947 citedByCount "28" @default.
• W2085002947 countsByYear W20850029472013 @default.
• W2085002947 countsByYear W20850029472015 @default.

• next